EGFR and esophageal squamous cell carcinoma: The results showed that DPT inhibited ESCC cell growth by targeting EGFR and related signaling, and induced cell cycle arrest and apoptosis through reactive oxygen species (ROS) production, mitochondrial membrane potential (MMP) depolarization, and multi-caspase activation in ESCC cells.